On June 17, 2022, the U.S. Food and Drug Administration (FDA) amended the Pfizer-BioNTech COVID-19 vaccine emergency use authorization to authorize use for all patients 6 months through 4 years of age. CMS issued new CPT codes effective June 17, 2022:
New ICD-10-CM Diagnosis Codes: Fiscal Year 2023
New ICD-10-PCS Procedure Codes: Fiscal Year 2023
The Centers for Medicare & Medicaid Services (CMS) has published the 2023 ICD-10 Procedure Coding System (ICD-10-PCS) codes and guidelines for the 2023 fiscal year.
AMA Announces CPT Update For Moderna Pediatric COVID-19 vaccine
The American Medical Association (AMA) announced an editorial update to Current Procedural Terminology (CPT), that includes new product and administration codes assigned to the Moderna COVID-19 vaccine for children 6 months through 5 years old.
The provisional CPT codes are effective for use on the condition that Moderna’s pediatric COVID-19 vaccine candidate is granted an Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).
New Administration Code for Pfizer Pediatric COVID-19 Vaccine Booster Dose
On May 17, 2022, the U.S. Food and Drug Administration (FDA) amended the Pfizer-BioNTech COVID-19 vaccine emergency use authorization (PDF) to authorize the use of a single booster pediatric dose (orange cap) for all patients 5 – 11 years old. The Centers for Medicare & Medicaid Services (CMS) issued a new code, effective May 17, 2022, for the vaccine administration.